| 发明名称 | Methods for treating HCV | ||
| 摘要 | This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions. | ||
| 申请公布号 | US9393256(B2) | 申请公布日期 | 2016.07.19 |
| 申请号 | US201313875252 | 申请日期 | 2013.05.01 |
| 申请人 | Gilead Pharmasset LLC | 发明人 | Ray Adrian S.;Link John O.;Oldach David W.;Delaney, IV William E.;Mo Hongmei;Yang Cheng Yong |
| 分类号 | A61K31/505;A61K31/415;A61K31/40;A61K31/34;A61K31/7072;A61K31/381;A61K31/4184;A61K31/4196;A61K31/513;A61K45/06;A61K31/7056;A61K38/21 | 主分类号 | A61K31/505 |
| 代理机构 | Sheppard Mullin Richter & Hampton LLP | 代理人 | Sheppard Mullin Richter & Hampton LLP |
| 主权项 | 1. A method of treating an HCV infection in a human, comprising administering to the human: 1) compound 10 having the structure: or a pharmaceutically acceptable salt thereof and 2) compound 6 having the structure: or a pharmaceutically acceptable salt thereof, wherein the method does not include administering interferon. | ||
| 地址 | Foster City CA US | ||